SLB:NYSESLB Limited Analysis
Data as of 2026-06-10 - not real-time
$55.51
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
SLN’s price sits just above a key support level, with the 20‑day SMA comfortably above the 50‑day SMA, confirming a short‑term bullish bias despite a bearish MACD crossover and a neutral RSI. Volume is on the rise and beta is sub‑market, but 30‑day volatility remains elevated, reflecting the sector’s sensitivity to crude‑price swings. Fundamentals show modest revenue growth, solid cash flow, and a sustainable 2% dividend, yet the current market price is well above the DCF‑derived fair value and carries a P/E premium versus the industry average, flagging an overvalued valuation. Recent headlines note a 3‑plus percent dip after a sharp WTI decline tied to geopolitical developments, adding short‑term downside pressure.
Given the analyst consensus of “buy” and a projected upside of roughly twelve percent, the stock offers a compelling dividend yield and medium‑term upside if oil‑price volatility stabilizes, but investors should remain cautious of the high valuation and sector‑specific risks.
Given the analyst consensus of “buy” and a projected upside of roughly twelve percent, the stock offers a compelling dividend yield and medium‑term upside if oil‑price volatility stabilizes, but investors should remain cautious of the high valuation and sector‑specific risks.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- Price hovering near support amid recent oil‑price decline
- Bearish MACD signal and elevated short‑term volatility
- Increasing volume indicating potential for a short‑term bounce
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Technical bullish trend with SMA20 above SMA50 and SMA200
- Projected upside of ~12% based on analyst targets
- Stable dividend yield and solid cash‑flow generation
Long Term
> 3 yearsNeutral
Model confidence: 6/10
Key Factors
- Sustainable dividend and reasonable payout ratio
- Modest revenue growth tempered by high debt levels
- Sector exposure to energy‑transition and regulatory shifts
Key Metrics & Analysis
Financial Health
Revenue Growth2.70%
Profit Margin9.26%
P/E Ratio24.5
ROE14.07%
ROA6.47%
Debt/Equity42.52
P/B Ratio3.2
Op. Cash Flow$6.3B
Free Cash Flow$3.0B
Industry P/E21.8
Technical Analysis
TrendBullish
RSI49.4
Support$53.97
Resistance$58.82
MA 20$56.27
MA 50$54.54
MA 200$44.38
MACDBearish
VolumeIncreasing
Fear & Greed Index81.75
Valuation
Fair Value$24.46
Target Price$62.21
Upside/Downside12.08%
GradeOvervalued
TypeBlend
Dividend Yield2.11%
Risk Assessment
Beta0.81
Volatility32.87%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.